https://www.taxtmi.com/news?id=33606 Datar Cancer Genetics appointed Dr. Massimo Cristofanilli as Strategic Advisor to collaborate with DCG research teams on molecular and functional tumor profiling, liquid biopsy technologies, circulating tumor cell analysis, and biomarker driven diagnostic and treatment personalization development; the announcement highlights the advisor's scientific credentials and DCG's accredited research centres while describing intended objectives of assay innovation, safety and reliability improvements, and expanded biomarker applications. en-us Tue, 11 Feb 2025 15:31:03 +0530 Tue, 11 Feb 2025 15:31:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=33606 Datar Cancer Genetics appointed Dr. Massimo Cristofanilli as Strategic Advisor to collaborate with DCG research teams on molecular and functional tumor profiling, liquid biopsy technologies, circulating tumor cell analysis, and biomarker driven diagnostic and treatment personalization development; the announcement highlights the advisor's scientific credentials and DCG's accredited research centres while describing intended objectives of assay innovation, safety and reliability improvements, and expanded biomarker applications. News - Tue, 11 Feb 2025 15:31:03 +0530 https://www.taxtmi.com/news?id=33606